This inventor holds 2 USPTO granted patents. Top assignees: Sequenom, Inc., University of California. Active years: 2008-2009.
Company Filing History:
2 out of 190 
1 out of 15,988 
Years Active: 2008-2009
Title: The Innovations of Stefan M Kammerer
Introduction
Stefan M Kammerer is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the area of breast cancer. With a total of 2 patents, his work has the potential to impact the lives of many individuals at risk of this disease.
Latest Patents
Kammerer's latest patents include innovative methods for identifying the risk of breast cancer. These methods involve analyzing polymorphic variations in nucleotide sequences within the human genome. Additionally, he has developed reagents and kits for carrying out these methods, as well as therapeutic methods for treating breast cancer in subjects. Another patent focuses on A-kinase anchor protein (AKAPs) muteins, peptides, and nucleic acids encoding these peptides. This work also includes the creation of transgenic animals and cells that comprise transgenes, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Kammerer has worked with reputable organizations such as Sequenom, Inc. and the University of California. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Andreas Braun and Christopher Self. Their collaboration has likely contributed to the success of Kammerer's innovative projects.
Conclusion
Stefan M Kammerer is a distinguished inventor whose work in breast cancer research has led to valuable patents and advancements in medical technology. His contributions continue to pave the way for future innovations in the field.